Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer
Vitamin C Intravenously With Chemotherapy and Adebrelimab in Metastatic Colorectal Cancer With High Expresison Level of GLUT3
Sponsor: Fudan University
A PHASE3 clinical study on Colorectal Cancer and GLUT3, this trial is actively recruiting participants. The trial is conducted by Fudan University and has accumulated 6 data snapshots since 2024. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
6 versions recorded-
Nov 2024 — Present [monthly]
Recruiting PHASE3
Status: Unknown → Recruiting
-
Sep 2024 — Nov 2024 [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Oct 2023 — Jul 2024 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
-
Jan 2021 — Oct 2023 [monthly]
Recruiting PHASE3
▶ Show 1 earlier version
-
Sep 2020 — Jan 2021 [monthly]
Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Fudan University
For direct contact, visit the study record on ClinicalTrials.gov .